PereiraB.J., LeveyA.S.Hepatitis C virus infection in dialysis and renal transplantation.Kidney Int1997; 51: 981–99.
2.
SemeK., PoljakM., Zuzek–ResekS., Avsic–ZupancT.High prevalence of hepatitis C virus infection in hemodialysis patients from one dialysis unit in Slovenia.Nephron1995; 71: 99–100.
3.
SampietroM., BadalamentiS., GrazianiG.Nosocomial hepatitis C in dialysis units.Nephron1996; 74: 251–60.
4.
HuangC.C., WuM.S., LinD.Y., LiawY.F.The prevalence of hepatitis C virus antibodies in patients treated with continuous ambulatory peritoneal dialysis.Perit Dial Int1992; 12: 31–3.
5.
Cendoroglo NetoM., ManzanoS.I., CanzianiM.E., SilvaA.E., CirenzaL.F.Environmental transmission of hepatitis B and hepatitis C viruses within the hemodialysis unit.Artif Organs1995; 19: 251–5.
6.
Le PogamS., Le ChapoisD., ChristenR., DuboisF., BarinF., GoudeauA.Hepatitis C in a hemodialysis unit: Molecular evidence for nosocomial transmission.J Clin Microbiol1998; 36: 3040–3.
7.
AkpolatT., ArikN., GünaydinM., UtasC., DilekK., ÇaglarS.Prevalence of anti-HCV among haemodialysis patients in Turkey: A multicentre study.Nephrol Dial Transplant1995; 10: 479–80.
8.
Dos SantosJ.P., LoureiroA., Cendoroglo NetoM., PereiraB.J.Impact of dialysis room and reuse strategies on the incidence of hepatitis C virus infection in haemodialysis units.Nephrol Dial Transplant1996; 11: 2017–22.
9.
Van BiesenW., VanholderR., LameireN.Impact of pretransplantation dialysis modality on patient outcome after renal transplantation: The role of peritoneal dialysis revisited.Perit Dial Int1999; 19: 103–6.
